Asthma, comorbidities, and aggravating circumstances: The gema-forum II task force

doi:10.18176/jiaci.0460

Asthma, comorbidities, and aggravating circumstances: The gema-forum II task force

Producció científica: Contribució a revista › Article › Recerca › Avaluat per experts

Idioma original	Anglès
Pàgines (de-a)	140-143
Nombre de pàgines	4
Revista	Journal of Investigational Allergology and Clinical Immunology
Volum	30
Número	2
DOIs	https://doi.org/10.18176/jiaci.0460
Estat de la publicació	Publicada - 2020

Accés al document

10.18176/jiaci.0460

Altres arxius i enllaços

Link to publication in Scopus

Com citar-ho

@article{51c3214574af49f5b00e95f07e578f94,

title = "Asthma, comorbidities, and aggravating circumstances: The gema-forum II task force",

keywords = "Asthma, Comorbidities, Diagnosis, Monitoring, Treatment",

author = "Trigueros, {Juan Antonio} and V. Plaza and J. Dom{\'i}nguez-Ortega and J. Serrano and C. Cisneros and A. Padilla and {Ant{\'o}n Giron{\'e}s}, M. and {Mosteiro M}, M and {Mart{\'i}nez Morag{\'o}n}, E. and {Olagu{\'i}bel Rivera}, {J. M.} and J. Delgado and {Garc{\'i}a Rivero}, {J. L.} and {Mart{\'i}nez Rivera}, C. and Garrido, {J. J.} and S. Quirce",

note = "Funding Information: In the last 3 years, Juan Jos{\'e} Garrido has received fees as speaker in scientific meetings sponsored by Zambon, AstraZeneca, GSK, Chiesi, and Novartis. He has also received financial assistance for attendance at congresses by Chiesi, Menarini, TEVA, and Novartis and funding for research projects from AstraZeneca and GSK.",

year = "2020",

doi = "10.18176/jiaci.0460",

language = "English",

volume = "30",

pages = "140--143",

journal = "Journal of Investigational Allergology and Clinical Immunology",

issn = "1018-9068",

publisher = "Esmon",

number = "2",

}

TY - JOUR

T1 - Asthma, comorbidities, and aggravating circumstances

T2 - The gema-forum II task force

AU - Trigueros, Juan Antonio

AU - Plaza, V.

AU - Domínguez-Ortega, J.

AU - Serrano, J.

AU - Cisneros, C.

AU - Padilla, A.

AU - Antón Gironés, M.

AU - Mosteiro M, M

AU - Martínez Moragón, E.

AU - Olaguíbel Rivera, J. M.

AU - Delgado, J.

AU - García Rivero, J. L.

AU - Martínez Rivera, C.

AU - Garrido, J. J.

AU - Quirce, S.

N1 - Funding Information: In the last 3 years, Juan José Garrido has received fees as speaker in scientific meetings sponsored by Zambon, AstraZeneca, GSK, Chiesi, and Novartis. He has also received financial assistance for attendance at congresses by Chiesi, Menarini, TEVA, and Novartis and funding for research projects from AstraZeneca and GSK.

PY - 2020

Y1 - 2020

KW - Asthma

KW - Comorbidities

KW - Diagnosis

KW - Monitoring

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=85084025645&partnerID=8YFLogxK

U2 - 10.18176/jiaci.0460

DO - 10.18176/jiaci.0460

M3 - Article

C2 - 31599723

AN - SCOPUS:85084025645

SN - 1018-9068

VL - 30

SP - 140

EP - 143

JO - Journal of Investigational Allergology and Clinical Immunology

JF - Journal of Investigational Allergology and Clinical Immunology

IS - 2

ER -